BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2017
View Archived Issues
BeiGene begins phase III study of BGB-3111
Read More
ConverGene enters research agreement with University of Maryland to evaluate drugs for leukemia
Read More
GlaxoSmithKline studies GSK-3117391 for rheumatoid arthritis in phase II trial
Read More
FDA approves new dosage strength of Linzess for CIC
Read More
Pfizer's C. difficile vaccine shows promising results in interim analysis of phase II study
Read More
X4 Pharmaceuticals starts phase I/II study of X4P-001 plus nivolumab in RCC
Read More
European Commission approves update to Jardiance label
Read More
Cellecta receives grant from NIH to advance CRISPR/Cas9 library technology
Read More
Exemplar Genetics contracted to create models of sickle cell disease
Read More
Pilot study result for ICMT-11 radiotracer for the assessment of apoptosis in AD
Read More
Johnson & Johnson announces highlights of fourth quarter 2016
Read More
Fruquintinib combined with paclitaxel in phase I/II gastric cancer trial
Read More
Bristol-Myers Squibb reflects on accomplishments of fourth quarter 2016
Read More
Phase II study reveals fosbretabulin activity in neuroendocrine tumors
Read More
Foresee announces topline results from phase III trial of FP-001 LMIS in advanced prostate cancer
Read More
ImmunoGen initiates phase I study of mirvetuximab soravtansine for platinum-resistant ovarian cancer
Read More
Acucela initiates phase IIa study of emixustat in macular atrophy secondary to Stargardt's disease
Read More
Jiangsu Chia Tai Tianqing, Centaurus BioPharma and Lianyungang Ruzhong patent EGFR mutant inhibitors
Read More
OncBioMune updates data from phase I trial of ProscaVax
Read More
Yokohama City University and QST divulge new AMPA receptor ligands
Read More
Tohoku University develops T-type calcium channel enhancer with potential for Alzheimer's disease
Read More
Deinobiotics identifies novel antibacterial bicyclic lipolantipeptides
Read More
CSIC, Universidad Miguel Hernandez disclose TRPM8 antagonists
Read More
Mitsubishi Tanabe and Biogen terminate MT-1303 license agreement
Read More
Tumoral caveolin-1 expression linked to gastric cancer progression
Read More
Eli Lilly terminates collaboration with Adocia on BioChaperone Lispro
Read More
Vicore Pharma's C-21 receives FDA orphan designation for idiopathic pulmonary fibrosis
Read More
Shionogi reports phase III data on S-524101 for house dust mite allergic rhinitis in children
Read More